Zobrazeno 1 - 10
of 1 277
pro vyhledávání: ''
Autor:
Matthew A. Allison, Bharath Ambale-Venkatesh, Mohammad R. Ostovaneh, Moyses Szklo, David A. Bluemke, Xiaoyang Ma, Colin O. Wu, Christopher Cox, Mary Cushman, Mahsima Shabani, Joao A.C. Lima, Matthew J. Budoff, David M. Herrington, Russell P. Tracy, Hooman Bakhshi, Michael J. Blaha
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 3769-3782 (2021)
ESC heart failure, vol 8, iss 5
ESC Heart Failure
ESC heart failure, vol 8, iss 5
ESC Heart Failure
Author(s): Shabani, Mahsima; Bakhshi, Hooman; Ostovaneh, Mohammad R; Ma, Xiaoyang; Wu, Colin O; Ambale-Venkatesh, Bharath; Blaha, Michael J; Allison, Matthew A; Budoff, Matthew J; Cushman, Mary; Tracy, Russell P; Herrington, David M; Szklo, Moyses; C
Publikováno v:
Vascular Health and Risk Management
Lipoprotein(a) forms a subfraction of the lipid profile and is characterized by the addition of apolipprotein(a) (apo(a)) to apoB100 derived particles. Its levels are mostly genetically determined inversely related to the number of protein domain (kr
Autor:
Byung Woo Jhun, Nam Yong Lee, Noeul Kang, Kyeongman Jeon, O Jung Kwon, Won-Jung Koh, Hee Jae Huh, Charles L. Daley, Hojoong Kim
Publikováno v:
Chest. 160:436-445
Mycobacterium abscessus pulmonary disease (M abscessus-PD) is challenging to treat because of its resistance to antibiotics.What are the outcomes of treatment-naive patients with M abscessus-PD treated with inhaled amikacin-containing multidrug regim
Autor:
Yue Wang, Hong-feng Jiang, Hai-ming Dang, Meng-ru Liu, Xin-yan Liu, Yang Yu, Jiang Xie, Xiao-jun Zhan, Hui-na Zhang, Xiao-fan Wu
Publikováno v:
Cardiovascular Drugs and Therapy. 36:805-815
It has been established that obstructive sleep apnea (OSA) is an independent risk factor for atherosclerosis. Chronic intermittent hypoxia (CIH) activates sympathoadrenal system and upregulates β3 adrenergic receptor (β3 AR). However, the effect of
Autor:
João Pedro Ferreira, Leong L. Ng, Chim C. Lang, Nicolas Girerd, Wouter Ouwerkerk, Kevin Duarte, Marco Metra, Gerasimos Filippatos, Patrick Rossignol, Kenneth Dickstein, Faiez Zannad, Adriaan A. Voors, Masatake Kobayashi, Dirk J. van Veldhuisen
Publikováno v:
Clinical Cardiology
Clinical Cardiology, Wiley, 2021, ⟨10.1002/clc.23576⟩
Clinical cardiology, 44(6), 780-788. Wiley-Blackwell
Clinical Cardiology, 44(6). Wiley
Clinical Cardiology, Wiley, 2021, ⟨10.1002/clc.23576⟩
Clinical cardiology, 44(6), 780-788. Wiley-Blackwell
Clinical Cardiology, 44(6). Wiley
International audience; Background: Achieving target doses of angiotensin-converting-enzyme inhibitor/angiotensin-receptor blockers (ACEi/ARB) and beta-blockers in heart failure with reduced ejection fraction (HFrEF) is often underperformed. In BIOlo
Publikováno v:
Circulation Journal. 85:759-768
Dyslipidemia is one of the most important risk factors for cardiovascular (CV) disease. Statin therapy has dramatically improved CV outcomes and is the backbone of current lipid-lowering therapy, but despite well-controlled low-density lipoprotein ch
Autor:
Harold E. Bays, Alberico L. Catapano, Joseph J. Saseen, Christie M. Ballantyne, Kausik K. Ray, Anne C. Goldberg
Publikováno v:
Cardiovascular Drugs and Therapy
Many patients do not achieve optimal low-density lipoprotein cholesterol (LDL-C) levels with statins alone; others are unable to tolerate statin therapy. Additional non-statin treatment options including ezetimibe, proprotein convertase subtilisin/ke
Autor:
Timothy R. Aksamit, David E. Griffith
Publikováno v:
Chest. 159:1372-1381
Management of Mycobacterium avium complex (MAC) lung disease is complicated, frequently unsuccessful, and frustrating to patients and clinicians. The initial treatment effort may not be directed solely at MAC infection, rather it is often initiating
Publikováno v:
Current Vascular Pharmacology. 19:390-397
Background: Statins are the mainstay of treatment for low-density lipoprotein cholesterol (LDL-C) lowering, however, some patients cannot tolerate statins because of adverse effects. Ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibit
Publikováno v:
Asian Cardiovascular and Thoracic Annals. 29:922-927
Context Protamine is used ubiquitously in all cardiac surgeries for reversal of heparin. Risk of postoperative bleeding is increased with inadequate heparin reversal or due to anticoagulant side effects of protamine; hence, it is important to dose pr